Cardiac Prosthetic Devices comprises of prosthetic heart valves such as mechanical heart valve and tissue heart valve along with annuloplasty rings, pacemaker leads, defibrillator leads, tissue patches, ventricular assist devices, and artificial hearts. These are used to replace damaged or diseased natural valves of the heart. Increasing prevalence of hypertension is expected to propel growth of the global cardiac prosthetic devices market over the forecast period. Furthermore, increasing research and product launches is also anticipated to assist the growth of the market.
Key features of the study:
- This report provides in-depth analysis of the Global Cardiac Prosthetic Devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the Global Cardiac Prosthetic Devices market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Abbott Laboratories, Abiomed, Inc., AtriCure, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation BIOTRONIK, Braile Biomedica, CryoLife, Inc., Labcor Laboratrios, Lepu Medical, Lifetech Scientific, LivaNova, MEDICO, Medtronic plc, Meril Life Sciences, MicroPort Scientific, Shree Pacetronix, TTK Healthcare, Venus Medtech, and Vitatron.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The Global Cardiac Prosthetic Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cardiac Prosthetic Devices market
Detailed Segmentation:
- Global Cardiac Prosthetic Devices Market, By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves
- Pacemaker
- Implantable Pacemaker
- External Pacemaker
- Global Cardiac Prosthetic Devices Market, By End User:
- Hospital
- Specialty Centers
- Others
- Global Cardiac Prosthetic Devices Market, By Region:
- North America
- By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves
- Pacemaker
- Implantable Pacemaker
- External Pacemaker
- By End User
- Hospital
- Specialty Centers
- Others
- By Country
- U.S.
- Canada
- Latin America
- By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves
- Pacemaker
- Implantable Pacemaker
- External Pacemaker
- By End User
- Hospital
- Specialty Centers
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves
- Pacemaker
- Implantable Pacemaker
- External Pacemaker
- By End User
- Hospital
- Specialty Centers
- Others
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves
- Pacemaker
- Implantable Pacemaker
- External Pacemaker
- By End User
- Hospital
- Specialty Centers
- Others
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves
- Pacemaker
- Implantable Pacemaker
- External Pacemaker
- By End User
- Hospital
- Specialty Centers
- Others
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves
- Pacemaker
- Implantable Pacemaker
- External Pacemaker
- By End User
- Hospital
- Specialty Centers
- Others
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Abbott Laboratories *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abiomed, Inc.
- AtriCure, Inc.
- Boston Scientific Corporation
- Edward Lifesciences Corporation
- BIOTRONIK
- Braile Biomedica
- CryoLife, Inc.
- Labcor Laboratrios
- Lepu Medical
- Lifetech Scientific
- LivaNova
- Medtronic plc.
- Meril Life Sciences
- MicroPort Scientific
- Shree Pacetronix
- TTK Healthcare
- Venus Medtech
- Vitatron
"*" marked represents similar segmentation in other categories in the respective section.